Antaros Medical continues to invest

Antaros Medical, the unique service provider pioneering new frontiers in drug development using innovative imaging, has today announced two key appointments – Klas Malmberg, as the Chief Medical Officer and Elisabeth Bolling-Sternevald, as the Chief Operating Officer.

Klas Malmberg MD, PhD, FESC, is an experienced cardiologist, medical expert and senior lecturer with wide experience from both academic and pharmaceutical industry.
Elisabeth Bolling-Sternevald, PhD (Doctor of medicine) brings in extensive global experience from disease area strategy work, drug portfolio development and global project leadership.

Both Klas and Elisabeth have been working in various countries in many years. Johannes Hulthe, Antaros Medical CEO commented: “We are very excited about getting Klas and Elisabeth on-board and we very much look forward to benefit from their robust medical and pharmaceutical leadership. We see both appointments as strategic investments which will further strengthen our abilities to empower our clients as evidence-based decision-makers in clinical drug development.

For more information about this media release, please contact: Johannes Hulthe at johannes.hulthe@antarosmedical.com

Full media release in english

Full media release in swedish